- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06569173
Comparison of Stent-Related Symptoms Between Anti-Reflux Stents and Standard DJ Stents in Children With Urolithiasis
November 11, 2024 updated by: Hongbo Liu, The Children's Hospital of Zhejiang University School of Medicine
Comparison of the Drainage/Anti-reflux Effect and Stent-Related Symptoms Between Anti-Reflux Stents and Standard DJ Stents in Children With Urolithiasis
The aim of this study is to investigate the effectiveness and related complications of anti-reflux stents used in pediatric urolithiasis surgery at the Children's Hospital affiliated with Zhejiang University School of Medicine, by comparing them with conventional stents.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Ureteral stents are crucial adjunctive devices following urolithiasis surgery, serving to support the ureter and facilitate urine drainage.
However, the application of these stents can lead to complications such as urinary tract infections, lumbar pain, and bladder irritative symptoms, which significantly impact the quality of life in pediatric patients.
Novel designs, such as anti-reflux stents equipped with valves, have been optimized to enhance unidirectional urine flow while effectively preventing retrograde urine flow.
It is anticipated that these designs could alleviate symptoms of lumbar pain and urinary tract infections, thereby improving the postoperative recovery quality in children.
Current adult studies suggest that anti-reflux stents might reduce urine reflux but may also be associated with significantly stronger urinary symptoms.
To date, there have been no pediatric studies reported on the efficacy of anti-reflux stents.
The aim of this study is to investigate the effectiveness and related complications of anti-reflux stents used in pediatric urolithiasis surgery at the Children's Hospital affiliated with Zhejiang University School of Medicine, by comparing them with conventional stents.
Study Type
Interventional
Enrollment (Estimated)
108
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aimei Ma
- Phone Number: +86 15888864134
- Email: maaimei@zju.edu.cn
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310052
- Recruiting
- Children's Hospital, Zhejiang University School of Medicine
-
Contact:
- Hongbo Liu
- Phone Number: +86 19329110160
- Email: 19329110160@zju.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- A definitive diagnosis of urinary tract stones by CT scan, with indications for ureteroscopic lithotripsy (URL), percutaneous nephrolithotomy (PCNL), laparoscopic/open stone extraction with or without robotic assistance, or combined endoscopic lithotripsy, and no contraindications;
- Age is less than 18 years old;
- For preschool children, the informed consent form is signed by the parents; for school-age children, the informed consent form is signed by both the parents and the child themselves.
Exclusion Criteria:
- A history of recurrent bladder irritative symptoms or urinary tract infections;
- Severe renal insufficiency, anatomical or functional solitary kidney, and other significant comorbidities that render the child unsuitable for participation in the study;
- Stent placement surgery within the past 3 months;
- Recent use of medications that may interfere with the study results, such as solifenacin;
- Stent removal surgery performed at an external medical facility.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: LaiKai Anti-Reflux Ureteral Stent (19903)
LaiKai Anti-Reflux Ureteral Stent (19903) arm received anti-reflux stent.
|
Ureteral stents are serving to support the ureter and facilitate urine drainage with an anti-reflux valve.
|
|
Active Comparator: LaiKai Ureteral Stent (92001024)
LaiKai Ureteral Stent (92001024) arm received regular ureteral stent.
|
Ureteral stents are serving to support the ureter and facilitate urine drainage.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The effect of stents on body pain
Time Frame: Two weeks after stents inserting and two weeks after stents removing
|
Inquire whether the child has experienced body pain, especially lumbar pain after the insert or removal of the stent.
If yes, assign a value of 1; if no, assign a value of 0. The higher the score, the worse the stent is in terms of relieving lumbar pain.
|
Two weeks after stents inserting and two weeks after stents removing
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The effect of stents on stone-free rate
Time Frame: Two weeks after stents inserting and two weeks after stents removing
|
Calculate the stone clearance rate for children three months and half a year after surgery.
The higher the stone clearance rate, the better the stent's effectiveness.
|
Two weeks after stents inserting and two weeks after stents removing
|
|
The effect of stents on urinary symptoms
Time Frame: Two weeks after stents inserting and two weeks after stents removing
|
Use a self-administered questionnaire to understand the children's daytime urination intervals, times getting up at night, number of urge urinary incontinence episodes, number of genuine urinary incontinence episodes, times of incomplete urination, times of burning sensation during urination, number of hematuria episodes, degree of hematuria, and overall impact of urinary tract symptoms.
Scores are assigned from 1 to 3 or 1 to 5 for different questions, with higher scores indicating poorer stent effectiveness in the corresponding dimension.
|
Two weeks after stents inserting and two weeks after stents removing
|
|
The effect of stents on daily activities and psychological well-being
Time Frame: Two weeks after stents inserting and two weeks after stents removing
|
Based on the questions in the self-administered questionnaire, including "Does the stent affect daily activities?", "Does the stent affect the child's social interactions?",
and "Does the stent cause the child to have feelings of inferiority?",
we understand the impact of the stent on the child's daily life and psychological well-being.
The results are categorized as "No impact", "Slight impact", and "Significant impact", with corresponding scores of "1-3 points".
The higher the score, the greater the adverse effect of the stent on the child.
|
Two weeks after stents inserting and two weeks after stents removing
|
|
The effect of stents on clinical presentation
Time Frame: Two weeks after stents inserting and two weeks after stents removing
|
Understand the impact of the stent on children's urinary tract infections, antibiotic use, and emergency department visits through a questionnaire.
The results are scored as "0-1" or "1-5", with higher scores indicating a greater adverse effect of the stent.
|
Two weeks after stents inserting and two weeks after stents removing
|
|
The effect of the stent on learning
Time Frame: Two weeks after stents inserting and two weeks after stents removing
|
Understand the impact of the stent on the child's learning situation through a questionnaire, with the results scored on a scale of "0-1".
The higher the score, the greater the adverse impact of the stent on learning.
|
Two weeks after stents inserting and two weeks after stents removing
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Hongbo Liu, Children's Hospital, Zhejiang University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 23, 2024
Primary Completion (Estimated)
August 23, 2025
Study Completion (Estimated)
August 23, 2025
Study Registration Dates
First Submitted
July 23, 2024
First Submitted That Met QC Criteria
August 21, 2024
First Posted (Actual)
August 23, 2024
Study Record Updates
Last Update Posted (Estimated)
November 12, 2024
Last Update Submitted That Met QC Criteria
November 11, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-IRB-0212-IR-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urolithiasis
-
Beni-Suef UniversityRecruiting
-
Singapore General HospitalUnknown
-
Kırıkkale UniversityCompletedKidney Calculi Nephrolithiasis Urolithiasis Renal Stone
-
University of Sao Paulo General HospitalCompletedUrolithiasis and Aging | Renal Calcul and Metabolic Diseases | Urolithiasis and OsteoporosisBrazil
-
EULIS Colloborative Research Working GroupUnknownKidney Calculi | Nephrolithiasis | Patient Compliance | Calcium Oxalate Urolithiasis
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingHealthy | Kidney Calculi | Nephrolithiasis | Urolithiasis | Kidney Stone | Nephrolithiasis, Calcium Oxalate | Oxaluria | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
-
London Health Sciences Centre Research Institute...St. Joseph's Health Care LondonCompletedKidney Calculi | Nephrolithiasis | Kidney Stone | Human | Calcium Oxalate Urolithiasis | Vitamin K 2 | Calcium Oxalate Kidney Stones | Calcium Phosphate UrolithiasisCanada
-
Catalysis SLCompletedKidney Calculi | Kidney Injury | Urolithiasis | Ureteral Calculi | Ureteral Obstruction | Renal Disease | Renal Stone | Ureteral Injury | Renal Injury | Urolithiasis, Calcium Oxalate | Urolithiasis; Lower Urinary TractNicaragua
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingHealthy | Kidney Calculi | Nephrolithiasis | Urolithiasis | Healthy Volunteer | Kidney Stones | Nephrolithiasis, Calcium Oxalate | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingKidney Calculi | Nephrolithiasis | Urolithiasis | Kidney Stone | Nephrolithiasis, Calcium Oxalate | Oxaluria | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
Clinical Trials on LaiKai anti-reflux ureteral stent
-
Beni-Suef UniversityRecruitingUrolithiasis | Ureteral Calculi | Ureteral Stent-Related SymptomsEgypt
-
University of California, San DiegoThe Ureteral Stent CompanyWithdrawn
-
The First Affiliated Hospital of Guangzhou Medical...Completed
-
University of Cape TownRecruitingEsophageal Cancer | Reflux, GastroesophagealSouth Africa
-
Weill Medical College of Cornell UniversityNot yet recruitingUreteral Stent-Related SymptomUnited States
-
Mayo ClinicActive, not recruiting
-
University of British ColumbiaWithdrawn
-
Case Comprehensive Cancer CenterWithdrawnHysterectomy
-
HydrumedicalClinical Academic Center (2CA-Braga); Blueclinical, Ltd.Recruiting